What is the projected value of the Cancer registry software market by 2030?

The market is forecast to reach USD 167.59 million by 2030, growing at an 11.17% CAGR. Read More

Which deployment model is expanding fastest?

Cloud-based solutions are advancing at a 12.45% CAGR, driven by lower upfront costs and remote accessibility. Read More

Why is Asia-Pacific the fastest-growing region?

Rapid growth in cancer incidence, expanding healthcare infrastructure, and new government-funded registries propel the region’s 11.93% CAGR. Read More

How are AI technologies affecting registry operations?

Natural-language processing and machine learning automate data abstraction, helping registries overcome tumor-registrar shortages and improve data timeliness. Read More

What are the main barriers to adoption among small providers?

High implementation costs, limited IT staff, and stringent data-security requirements hinder uptake, especially in developing markets. Read More

Which companies recently made strategic moves in this space?

Health Catalyst’s 2024 acquisition of Carevive Systems and Varian’s partnership with Siemens Healthineers illustrate ongoing consolidation and technology integration trends. Read More

Cancer Registry Software Companies

This report lists the top Cancer Registry Software companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Cancer Registry Software industry.